Tuesday, September 23, 2014

Acute Spinal Cord Injury Global Clinical Trials Industry Review, H1, 2014

The Report “Acute Spinal Cord Injury Global Clinical Trials Review, H1, 2014″ is now available at lifescienceindustryresearch.com Contact sales@lifescienceindustryresearch.com  with Report name in subject line and your contact details to purchase this report or get your questions answered.

Researcher’s clinical trial report, “Acute Spinal Cord Injury Global Clinical Trials Review, H1, 2014″ provides data on the Acute Spinal Cord Injury clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Acute Spinal Cord Injury. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Acute Spinal Cord Injury. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Researcher’s team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

List of Figures
Acute Spinal Cord Injury Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Acute Spinal Cord Injury Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Acute Spinal Cord Injury Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Acute Spinal Cord Injury Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 10
Acute Spinal Cord Injury Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Acute Spinal Cord Injury Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Acute Spinal Cord Injury Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 13
Proportion of Acute Spinal Cord Injury to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 14
Acute Spinal Cord Injury Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Acute Spinal Cord Injury Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Acute Spinal Cord Injury to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 17
Acute Spinal Cord Injury Therapeutics, Global, Clinical Trials by Phase (%), 2014* 18
Acute Spinal Cord Injury Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 19
Acute Spinal Cord Injury Therapeutics, Global, Clinical Trials by Trial Status, 2014* 20
Acute Spinal Cord Injury Therapeutics Clinical Trials, Global, by End Point Status, 2014* 21
Acute Spinal Cord Injury Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 24


Inquiry before buying this Report @ http://www.lifescienceindustryresearch.com/inquire-before-buying?rname=15874 .  (Single User License : US$ 2500 And Corporate User License : US$ 7500)


For further information on “Acute Spinal Cord Injury Global Clinical Trials Review, H1, 2014” report Contact sales@lifescienceindustryresearch.com / Call +1 888 391 5441.